Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IgPro20 Extension Study in Primary Immunodeficiency
NCT00751621Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Aug 2008
- Primary completion
- Dec 2011
- Modality
- Biologic
- Countries
- 8
01
Overview
A Phase 3 trial of IgPro10 in primary immunodeficiency (PI), sponsored by CSL Limited. Started Aug 2008; status: completed.
02
Drugs
IgPro10
03
Conditions
primary immunodeficiency (PI)
Beyond the preview
Go deeper on NCT00751621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751621.